Market Overview

Cowen Downgrades Cameco To Market Perform

Share:
Related CCJ
Best & Worst ETFs Of The Week Amid Tech Fueled Breakout
Cameco Upgraded To Buy At BofA, Cites 'Limited Downside In Bad Macro'
Utilities Staying Out Of The Uranium Market, But Cameco's Outlook Remains Robust (Seeking Alpha)

Analysts at Cowen & Company downgraded Cameco (NYSE: CCJ) from Outperform to Market Perform.

The target price for Cameco has been lowered from $25 to $20.

Cameco shares have gained 6.69% over the past 52 weeks, while the S&P 500 index has surged 19.89% in the same period.

Cameco's shares gained 1.58% to close at $20.56 yesterday.

Latest Ratings for CCJ

DateFirmActionFromTo
Apr 2015Raymond JamesUpgradesMarket PerformOutperform
Apr 2015Bank of AmericaUpgradesNeutralBuy
Apr 2015Canaccord GenuityUpgradesHoldBuy

View More Analyst Ratings for CCJ
View the Latest Analyst Ratings

Posted-In: Cowen & CompanyDowngrades Analyst Ratings

 

Related Articles (CCJ)

Around the Web, We're Loving...